Yi Zuo to Pulmonary Surfactants
This is a "connection" page, showing publications Yi Zuo has written about Pulmonary Surfactants.
Connection Strength
9.207
-
Li G, Xu X, Sun B, Zuo YY. Biophysical mechanisms of SARS-CoV-2-induced surfactant inhibition. Biophys J. 2025 Nov 04; 124(21):3733-3741.
Score: 0.920
-
Zuo YY. Comparative biophysical study of clinical surfactants using constrained drop surfactometry. Am J Physiol Lung Cell Mol Physiol. 2024 Oct 01; 327(4):L535-L546.
Score: 0.854
-
Xu X, Goros RA, Dong Z, Meng X, Li G, Chen W, Liu S, Ma J, Zuo YY. Microplastics and Nanoplastics Impair the Biophysical Function of Pulmonary Surfactant by Forming Heteroaggregates at the Alveolar-Capillary Interface. Environ Sci Technol. 2023 12 19; 57(50):21050-21060.
Score: 0.813
-
Goros RA, Xu X, Li G, Zuo YY. Adverse Biophysical Impact of e-Cigarette Flavors on Pulmonary Surfactant. Environ Sci Technol. 2023 10 24; 57(42):15882-15891.
Score: 0.805
-
Li G, Xu X, Zuo YY. Biophysical function of pulmonary surfactant in liquid ventilation. Biophys J. 2023 08 08; 122(15):3099-3107.
Score: 0.788
-
Li G, Xu X, Zuo YY. Phase transitions of the pulmonary surfactant film at the perfluorocarbon-water interface. Biophys J. 2023 05 16; 122(10):1772-1780.
Score: 0.777
-
Xu X, Li G, Sun B, Zuo YY. S2 Subunit of SARS-CoV-2 Spike Protein Induces Domain Fusion in Natural Pulmonary Surfactant Monolayers. J Phys Chem Lett. 2022 Sep 08; 13(35):8359-8364.
Score: 0.745
-
Xu L, Yang Y, Simien JM, Kang C, Li G, Xu X, Haglund E, Sun R, Zuo YY. Menthol in electronic cigarettes causes biophysical inhibition of pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol. 2022 08 01; 323(2):L165-L177.
Score: 0.736
-
Xu L, Yang Y, Zuo YY. Atomic Force Microscopy Imaging of Adsorbed Pulmonary Surfactant Films. Biophys J. 2020 08 18; 119(4):756-766.
Score: 0.643
-
Yang Y, Xu L, Dekkers S, Zhang LG, Cassee FR, Zuo YY. Aggregation State of Metal-Based Nanomaterials at the Pulmonary Surfactant Film Determines Biophysical Inhibition. Environ Sci Technol. 2018 08 07; 52(15):8920-8929.
Score: 0.560
-
Zhang H, Wang YE, Neal CR, Zuo YY. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant. Pediatr Res. 2012 Apr; 71(4 Pt 1):316-23.
Score: 0.359
-
Fan Q, Wang YE, Zhao X, Loo JS, Zuo YY. Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. ACS Nano. 2011 Aug 23; 5(8):6410-6.
Score: 0.345
-
Zhang H, Wang YE, Fan Q, Zuo YY. On the low surface tension of lung surfactant. Langmuir. 2011 Jul 05; 27(13):8351-8.
Score: 0.342
-
Zhang H, Fan Q, Wang YE, Neal CR, Zuo YY. Comparative study of clinical pulmonary surfactants using atomic force microscopy. Biochim Biophys Acta. 2011 Jul; 1808(7):1832-42.
Score: 0.337
-
Hu Q, Jiao B, Shi X, Valle RP, Zuo YY, Hu G. Effects of graphene oxide nanosheets on the ultrastructure and biophysical properties of the pulmonary surfactant film. Nanoscale. 2015 Nov 21; 7(43):18025-9.
Score: 0.116
-
S?rli JB, Balogh Sivars K, Da Silva E, Hougaard KS, Koponen IK, Zuo YY, Weydahl IEK, ?berg PM, Fransson R. Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects. Int J Pharm. 2018 Oct 25; 550(1-2):114-122.
Score: 0.035
-
Chen Y, Yang Y, Xu B, Wang S, Li B, Ma J, Gao J, Zuo YY, Liu S. Mesoporous carbon nanomaterials induced pulmonary surfactant inhibition, cytotoxicity, inflammation and lung fibrosis. J Environ Sci (China). 2017 Dec; 62:100-114.
Score: 0.033